Abstract OT1-03-06: Phase IB/II clinical trial to evaluate safety and efficacy of tucatinib in combination with palbociclib and letrozole in patients with hormone receptor positive and HER2-positive metastatic breast cancer
Shagisultanova, E, Diamond, J, Stopeck, A, Pusztai, L, O'Regan, R, Gradishar, W, Brown-Glaberman, U, Chalasani, P, McSpadden, T, Borakove, M, Shedin, T, Kabos, P, Borges, V
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article